FDA approves 'Jascayd for progressive pulmonary fibrosis: What it means for patients

Exciting news for those affected by progressive pulmonary fibrosis (PPF): The US FDA has granted approval for Jascayd (nerandomilast). This groundbreaking medication goes beyond merely alleviating symptoms, presenting a scientifically validated way to decelerate lung damage.

from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/7zOTIX2
via IFTTT